352 related articles for article (PubMed ID: 24813415)
1. Intranasal immunisation of the recombinant Toxoplasma gondii receptor for activated C kinase 1 partly protects mice against T. gondii infection.
Wang HL; Pang M; Yin LT; Zhang JH; Meng XL; Yu BF; Guo R; Bai JZ; Zheng GP; Yin GR
Acta Trop; 2014 Sep; 137():58-66. PubMed ID: 24813415
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.
Wang HL; Wen LM; Pei YJ; Wang F; Yin LT; Bai JZ; Guo R; Wang CF; Yin GR
Parasite; 2016; 23():12. PubMed ID: 26984115
[TBL] [Abstract][Full Text] [Related]
3. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes.
Wang T; Yin H; Li Y; Zhao L; Sun X; Cong H
Parasite; 2017; 24():12. PubMed ID: 28367800
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.
Rashid I; Moiré N; Héraut B; Dimier-Poisson I; Mévélec MN
Med Microbiol Immunol; 2017 Feb; 206(1):53-62. PubMed ID: 27757545
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice.
Yin LT; Ren YJ; You YJ; Yang Y; Wang ZX; Wang HL
Parasite; 2023; 30():46. PubMed ID: 37921620
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ
Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
[TBL] [Abstract][Full Text] [Related]
11. Partial protective immunity against toxoplasmosis in mice elicited by recombinant Toxoplasma gondii malate dehydrogenase.
Liu Z; Yuan F; Yang Y; Yin L; Liu Y; Wang Y; Zheng K; Cao J
Vaccine; 2016 Feb; 34(7):989-94. PubMed ID: 26514423
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.
Yin LT; Hao HX; Wang HL; Zhang JH; Meng XL; Yin GR
PLoS One; 2013; 8(12):e82765. PubMed ID: 24386114
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice.
Liu Z; Yin L; Li Y; Yuan F; Zhang X; Ma J; Liu H; Wang Y; Zheng K; Cao J
BMC Immunol; 2016 Oct; 17(1):37. PubMed ID: 27716047
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model.
Chu JQ; Huang S; Ye W; Fan XY; Huang R; Ye SC; Yu CY; Wu WY; Zhou Y; Zhou W; Lee YH; Quan JH
Korean J Parasitol; 2018 Aug; 56(4):325-334. PubMed ID: 30196664
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice.
Zhang TE; Yin LT; Li RH; Wang HL; Meng XL; Yin GR
Parasit Vectors; 2015 Jan; 8():15. PubMed ID: 25582167
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.
Stanley AC; Buxton D; Innes EA; Huntley JF
Vaccine; 2004 Sep; 22(29-30):3929-41. PubMed ID: 15364441
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re.
Qu D; Han J; Du A
Exp Parasitol; 2013 Oct; 135(2):234-9. PubMed ID: 23896123
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
